Skip to main content

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Coit, DG; Thompson, JA; Albertini, MR; Barker, C; Carson, WE; Contreras, C; Daniels, GA; DiMaio, D; Fields, RC; Fleming, MD; Freeman, M ...
Published in: J Natl Compr Canc Netw
April 1, 2019

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

April 1, 2019

Volume

17

Issue

4

Start / End Page

367 / 402

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Oncology & Carcinogenesis
  • Melanoma, Cutaneous Malignant
  • Melanoma
  • Medical Oncology
  • Humans
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Coit, D. G., Thompson, J. A., Albertini, M. R., Barker, C., Carson, W. E., Contreras, C., … Engh, A. M. (2019). Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(4), 367–402. https://doi.org/10.6004/jnccn.2019.0018
Coit, Daniel G., John A. Thompson, Mark R. Albertini, Christopher Barker, William E. Carson, Carlo Contreras, Gregory A. Daniels, et al. “Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 17, no. 4 (April 1, 2019): 367–402. https://doi.org/10.6004/jnccn.2019.0018.
Coit DG, Thompson JA, Albertini MR, Barker C, Carson WE, Contreras C, et al. Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Apr 1;17(4):367–402.
Coit, Daniel G., et al. “Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 17, no. 4, Apr. 2019, pp. 367–402. Pubmed, doi:10.6004/jnccn.2019.0018.
Coit DG, Thompson JA, Albertini MR, Barker C, Carson WE, Contreras C, Daniels GA, DiMaio D, Fields RC, Fleming MD, Freeman M, Galan A, Gastman B, Guild V, Johnson D, Joseph RW, Lange JR, Nath S, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Wuthrick E, McMillian NR, Engh AM. Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Apr 1;17(4):367–402.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

April 1, 2019

Volume

17

Issue

4

Start / End Page

367 / 402

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Oncology & Carcinogenesis
  • Melanoma, Cutaneous Malignant
  • Melanoma
  • Medical Oncology
  • Humans
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis